Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure-based drug repurposing: Traditional and advanced AI/ML-aided methods
Chinmayee Choudhury, N. Arul Murugan, U. Deva Priyakumar
Drug Discovery Today (2022) Vol. 27, Iss. 7, pp. 1847-1861
Open Access | Times Cited: 80

Showing 26-50 of 80 citing articles:

A Computational Framework for Predicting Novel Drug Indications Using Graph Convolutional Network With Contrastive Learning
Yuxun Luo, Wenyu Shan, Peng Li, et al.
IEEE Journal of Biomedical and Health Informatics (2024) Vol. 28, Iss. 8, pp. 4503-4511
Closed Access | Times Cited: 3
The future of metronomic chemotherapy: experimental and computational approaches of drug repurposing
Yousef A. Abdelrady, Hayam S. Thabet, Ahmed M. Sayed
Pharmacological Reports (2024)
Closed Access | Times Cited: 3
Bias-force guided simulations combined with experimental validations towards GPR17 modulators identification
Sana Kari, Akshaya Murugesan, Thiyagarajan Ramesh, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114320-114320
Open Access | Times Cited: 8
In silico screening of phytoconstituents as potential anti-inflammatory agents targeting NF-κB p65: an approach to promote burn wound healing
Saswati Pattnaik, Sneha Murmu, Bibhu Prasad Rath, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-29
Closed Access | Times Cited: 2
Applications of AI in Drug Discovery
Kalpana Pravin Rahate, Ritam Mondal
Advances in medical technologies and clinical practice book series (2024), pp. 86-120
Closed Access | Times Cited: 2
Drug repurposing for neurodegenerative diseases
Halak Shukla, D. James B. St. John, Shuvomoy Banerjee, et al.
Progress in molecular biology and translational science (2024), pp. 249-319
Closed Access | Times Cited: 2
Unlocking the potential of signature-based drug repurposing for anticancer drug discovery
Sruti Biswal, Bibekanand Mallick
Archives of Biochemistry and Biophysics (2024) Vol. 761, pp. 110150-110150
Closed Access | Times Cited: 2
Computational Screening of Approved Drugs for Inhibition of the Antibiotic Resistance Gene mecA in Methicillin-Resistant Staphylococcus aureus (MRSA) Strains
Benson Otarigho, Mofolusho O. Falade
BioTech (2023) Vol. 12, Iss. 2, pp. 25-25
Open Access | Times Cited: 6
Hybrid neural network approaches to predict drug–target binding affinity for drug repurposing: screening for potential leads for Alzheimer’s disease
Xia-lin Wu, Zhuojian Li, Guanxing Chen, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 6
A comprehensive review on structural and therapeutical insight of Cerebroside sulfotransferase (CST) - An important target for development of substrate reduction therapy against metachromatic leukodystrophy
Nivedita Singh, Ajay Singh
International Journal of Biological Macromolecules (2023) Vol. 258, pp. 128780-128780
Closed Access | Times Cited: 6
Drug Mechanism: A bioinformatic update
Martina Cirinciani, Eleonora Da Pozzo, Maria Letizia Trincavelli, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116078-116078
Closed Access | Times Cited: 2
Process and Applications of Structure‐Based Drug Design
M. Shanmuga Sundari, Sree Aiswarya Thotakura, Mounika Dharmana, et al.
(2024), pp. 321-368
Closed Access | Times Cited: 2
In Silico Drug Repurposing Against PSMB8 as a Potential Target for Acute Myeloid Leukemia Treatment
Ezgi Yağmur Tükel, Onur Ateş, Yağmur Kiraz
Molecular Biotechnology (2024)
Closed Access | Times Cited: 2
Recent progress in artificial intelligence and machine learning for novel diabetes mellitus medications development
Qi Guo, Bo Fu, Yuan Tian, et al.
Current Medical Research and Opinion (2024) Vol. 40, Iss. 9, pp. 1483-1493
Closed Access | Times Cited: 2
Unveiling 1,3-Thiazine Derivative as a Potential Neuraminidase Inhibitor: Molecular Docking, Molecular Dynamics, ADMET and DFT Studies
Mustapha Abdullahi, Adamu Uzairu, Gideon Adamu Shallangwa, et al.
Chemistry Africa (2023) Vol. 6, Iss. 6, pp. 2957-2967
Closed Access | Times Cited: 5
In silico drug repurposing carvedilol and its metabolites against SARS-CoV-2 infection using molecular docking and molecular dynamic simulation approaches
Chunye Zhang, Jiazheng Liu, Yuxiang Sui, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Advances in Predicting Drug Functions: A Decade-Long Survey in Drug Discovery Research
Pranab Das, Dilwar Hussain Mazumder
IEEE Transactions on Molecular Biological and Multi-Scale Communications (2023) Vol. 10, Iss. 1, pp. 75-91
Closed Access | Times Cited: 5
Artificial Intelligence Approaches in Drug Discovery: Towards the Laboratory of the Future
Luisa Frusciante, Anna Visibelli, Michela Geminiani, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 26, pp. 2176-2189
Closed Access | Times Cited: 8
Secure quantum computing for healthcare sector: A short analysis
Srikanth Pulipeti, Adarsh Kumar
Security and Privacy (2022) Vol. 6, Iss. 5
Open Access | Times Cited: 8
Emerging trends in computational approaches for drug discovery in molecular biology
Yakubu Magaji Yuguda, Israel Ebehitale Unuebho, Tejonidhi kolli, et al.
GSC Biological and Pharmaceutical Sciences (2023) Vol. 24, Iss. 3, pp. 202-213
Open Access | Times Cited: 4
Comparative molecular docking and toxicity between carbon-capped metal oxide nanoparticles and standard drugs in cancer and bacterial infections
Navid Mohammadjani, Sahand Karimi, Musa Moetasam Zorab, et al.
Bioimpacts (2023) Vol. 14, pp. 27778-27778
Open Access | Times Cited: 4
smProdrugs: A repository of small molecule prodrugs
Chinmayee Choudhury, Vivek Kumar, Rakesh Kumar
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115153-115153
Closed Access | Times Cited: 4
Synergizing drug repurposing and target identification for neurodegenerative diseases
Mehar Sahu, Shrutikirti Vashishth, Neha Kukreti, et al.
Progress in molecular biology and translational science (2024), pp. 111-169
Closed Access | Times Cited: 1
Physical formula enhanced multi-task learning for pharmacokinetics prediction
Yuqiang Li, Ruifeng Li, Dongzhan Zhou, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Promising tools for future drug discovery and development in antiarrhythmic therapy
Gema Mondéjar‐Parreño, Patricia Sánchez-Pérez, Francisco M. Cruz, et al.
Pharmacological Reviews (2024) Vol. 77, Iss. 1, pp. 100013-100013
Open Access | Times Cited: 1

Scroll to top